Abstract
The first human retroviruses to be discovered, human T lymphotropic virus type I (HTLV-I) and human T lymphotropic virus type II (HTLV-II) were reported in 1980 and 1982, respectively.1,2 HTLV-I was soon associated with adult T cell leukemia/lymphoma (ATL), a lymphoproliferative illness first reported in Japan in 1977. In 1985 a neurologic illness, now called HTLV-I-associated myelopathy/tropical spastic para-paresis (HAM/TSP), was also associated with HTLV-I. In contrast, HTLV-II, which was initially thought to be associated with hairy cell leukemia, has not been clearly associated with any disease. Screening of volunteer blood donors for HTLV-I began in 1986 in Japan and in 1988 in the United States; screening is also performed in Canada, France, the French West Indies, and Trinidad-Tobago.3
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type-c retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415–7419
Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, et al. A new subtype of human T-cell leukemia virus (I-ITLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982;218:571–573
Kaplan JE, Khabbaz RF. The epidemiology of human T-lymphotropic virus types I and II. Rev Med Virol 1993;3:137–148
Centers for Disease Control, Human T-lymphotropic virus type I screening in volunteer blood donors—United States, 1989. MMWR 1990;39:915, 921–924
Vitek CR, Gracia F, Fukuda K, et al. Evidence for sexual and mother-tochild transmission of HTLV-II among Guaymi Indians, Panama. Presented at the annual meeting of Laboratory of Tumor Cell Biology, Bethesda, August 1993
Centers for Disease Control. Licensure of screening tests for antibody to human T-Iymphotropic virus type I. MMWR 1988;37:736–740, 745–747
Lillehoj EP, Alexander SS, Dubrule CJ, et al. Development and evaluation of human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide. J Clin Microbiol 1990;28:2653–2658
Hartley TM, Khabbaz RF, Cannon RO, Kaplan JE, Lairmore MD. Immunoblot and immunoprecipitation tests for human T-cell Iymphotropic virus types I/II: patterns of immune reactivity. J Clin Microbiol 1990;28:646–650
Kwok S, Lipka JJ, McKinney N, et al. Low incidence of HTLV infections in random blood donors with indeterminate Western blot patterns. Transfusion 1990;30:491–494
Busch MP, Kleinman S, Calabro M, Laycock M, Thompson R. Evaluation of anti-FITLV supplemental testing in U.S. blood donors [abstract]. Presented at the American Association of Blood Banks 45th Annual Meeting, San Francisco, November 1992
Khabbaz RF, Heneine W., Grindon A, et al. Indeterminate HTLV serologic results in U.S. blood donors: are they due to HTLV-I or HTLV-II? J Acquit Immune Defic Syndr 1992;5:400–404
Donegan E, Pell P, Lee H, et al. Transmission of human T-lymphotropic virus type I by blood components from a donor lacking anti-p24: a case report. Transfusion 1992;32:68–71
Kleinman SH, Kaplan JE, Khabbaz RF, et al. Evaluation of a p2le spiked Western blot in confirming HTLV-I/II infection in volunteer blood donors. J Clin Microbiol 1994:32:603–607
Wiktor SZ, Piot P, Mann JM, Nzilambi N. et al. Human T cell lymphotropic virus type 1 (HTLV-I) among female prostitutes in Kinshasa, Zaire. J Infect Dis 1990;161:1073--1077
Lal RB, Heneine W, Rudolph DL, et al. Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals. J Clin Microbiol 1991;29:2253–2258
Lipka JJ, Miyoshi 1, Hadlock KG, et al. Segregation of human T cell lympiiotrophic virus type I and II infections by antibody reactivity to unique viral epitopes. J Infect Dis 1992;165:268–272
Chen Y-MA, Lee T-H, Wiktor SZ, et al. Type-specific antigens for serologic discrimination of HTLV-I and HTLV-II infection. Lancet 1990;336:1153–1155
Fang CT, Akins R, Sandler SG. An HTLV-1 EIA using recombinant envencoded peptides. Transfusion 1989;29(S):55f
Heneine W, Khabbaz RF, Lal RB, et al. Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II-infections in HTLV-I/II seropositive individuals. J Clin Microbiol 1992;30:1605–1607
Kwok S., Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237–239
Gessain A, Louie A, Gout O, Gallo RC, Franchini G. Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/ HTLV-I-associated myelopathy. J Virol 1991;65:4398–4407
Kinishita T, Shimoyama M, Tobinai K, et al. Detection of m-RNA for the taxi/rexl gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by the polymerase chain reaction. Proc Natl Acad Sci USA 1989;86:5620–5624
Kimata J, Ratner L. Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization. J Virol 1991;65:1628–1633
Zaki SR, Heneine W, Coffield LM, Greer PW, Folks TM. Intracellular in situ PCR amplification and detection of human T-cell lymphotropic virus type I (HTLV-I) DNA. Lab Invest 1992;66:95A
Yamaguchi K, Seiki M, Yoshida M, et al. The detection of human T cell leukemia virus proviral DNA and its application for classification and diagnosis of T cell malignancy. Blood 1984;63:1235–1240
Bleike MA, Riding ID, Gravell N, et al. In situ hybridization detection of HTLV-I RNA in TSP/HAM patients and their spouses. J Med Virol 1991; 33:64–71
Kitamura K, Rudolph D, Goldsmith C, Folks TM, Lal RB. Isolation, characterization, and transmission of human T lymphotropic virus types I and II in culture. Curr Microbiol 1993;27:355–360
Kitamura K, Heneine W, Lal R, Folks T. Sensitive detection of HTLV-I and HTLV-II viral particles in culture supernatants using a reverse transcriptasePCR assay. Presented at the American Society for Microbiology 92nd Annual meeting, New Orleans, 1992
Centers for Disease Control and Prevention, USPHS Working Group. Guidelines for counseling persons infected with human T-Iymphotropic virus type I (HTLV-I) and type II (HTLV-II). Ann Intern Med 1993;118:448–454
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Khabbaz, R.F., Heneine, W., Kaplan, J.E. (1994). Testing for Other Human Retroviruses: HTLV-I and HTLV-II. In: Schochetman, G., George, J.R. (eds) AIDS Testing. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-0867-9_11
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0867-9_11
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-6927-4
Online ISBN: 978-1-4612-0867-9
eBook Packages: Springer Book Archive